Ghana was earmarked as one of many 145 international locations of the UN-led COVAX Facility to take supply of two.4 million doses of the AstraZeneca vaccine which is licensed to the Serum Institute of India (AZ/SII).
The vaccine is anticipated to be administered to individuals in key sectors corresponding to well being staff within the first quarter.
In the meantime, a natural drugs, Cryptolepis sanguinolenta, was accredited for a scientific trial in Ghana for the therapy of COVID-19.
SEE ALSO :Drama ensues as man will get caught whereas in motion with a married lady
Identified domestically as ‘Nibima’, Cryptolepis sanguinolenta’s approval for the trial was introduced on Monday, February 1, 2021, by the Meals and Medication Authority (FDA).
The natural drugs developed by the College of Public Well being on the Kwame Nkrumah College of Science and Know-how (KNUST) was submitted to the FDA for the scientific trial in September 2020 and approval was granted in January 2021.
Ghana has had 80,253 instances of the virus and 577 deaths. The nation at present has 6,658 lively instances of an infection, in keeping with the newest replace from the Ghana Well being Service.